Director/PDMR Shareholding
26 sept. 2016 11h00 HE
|
AstraZeneca PLC
26 September 2016 16:00
Transaction by Person Discharging Managerial Responsibilities
Disclosure Rule DTR 3.1.4
On 26 September 2016, the interest of Sean Bohen, a person discharging
managerial...
Director Declaration
22 sept. 2016 06h00 HE
|
AstraZeneca PLC
22 September 2016 11.00
New external board appointment
Listing Rule LR 9.6.14 R (2)
Ann Cairns, a Non-Executive Director of AstraZeneca PLC, is expected to join the
Board of Directors of...
AstraZeneca Completes Aspen Agreement
01 sept. 2016 02h00 HE
|
AstraZeneca PLC
ASTRAZENECA COMPLETES COMMERCIALISATION AGREEMENT WITH ASPEN FOR ANAESTHETICS
PORTFOLIO
01 September 2016 07:00 BST
ASTRAZENECA COMPLETES COMMERCIALISATION AGREEMENT WITH ASPEN FOR...
AZ TO SELL ANTIBIOTICS BUSINESS TO PFIZER
24 août 2016 02h00 HE
|
AstraZeneca PLC
This announcement contains inside information
24 August 2016 07:00
ASTRAZENECA TO SELL SMALL MOLECULE
ANTIBIOTICS BUSINESS TO PFIZER
Value-creating divestment supports AstraZeneca’s focus on three...
Director Declaration
18 août 2016 08h00 HE
|
AstraZeneca PLC
18 August 2016 13:00
New external board appointment
Listing Rule LR 9.6.14 R (2)
Graham Chipchase, a Non-Executive Director of AstraZeneca PLC, has been
appointed as Chief Executive Officer and a...
AstraZeneca completes agreement with LEO Pharma
16 août 2016 02h00 HE
|
AstraZeneca PLC
This announcement contains inside information
16 August 2016 07:00
ASTRAZENECA COMPLETES GLOBAL LICENCING
AGREEMENT WITH LEO PHARMA FOR TRALOKINUMAB
AstraZeneca today announced that it has...
ASTRAZENECA ANNOUNCES INVESTMENT IN MODERNA
10 août 2016 09h58 HE
|
AstraZeneca PLC
This announcement contains inside information
10 August 2016 14:35
ASTRAZENECA ANNOUNCES INVESTMENT IN MODERNA
AstraZeneca today announced that it has increased its equity interest in...
ASTRAZENECA UPDATE ON SELUMETINIB PHASE III TRIAL
09 août 2016 02h00 HE
|
AstraZeneca PLC
This announcement contains inside information
09 August 2016 07:00
ASTRAZENECA PROVIDES UPDATE ON PHASE III TRIAL OF SELUMETINIB IN NON-SMALL CELL
LUNG CANCER
Selumetinib did not meet trial...
Director/PDMR Shareholding
01 août 2016 06h00 HE
|
AstraZeneca PLC
Transaction by Person Discharging Managerial Responsibilities
Disclosure Rule DTR 3.1.4
On 1 August 2016, the interest of Marc Dunoyer, a person discharging managerial
responsibilities, in the...
AZN: H1 2016 Results
28 juil. 2016 02h46 HE
|
AstraZeneca PLC
AstraZeneca PLC
28 July 2016 07:00
This announcement contains inside information.
H1 2016 Results
Financial Summary
H1 2016 Q2 2016
...